David Kluge, MD
Otolaryngology · Great Falls, MTNPI 1376765420
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Stryker at 27.2% of the total. 2025 is the largest year on record at $138, more than ten times the $13 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in MT, where the typical reported total is $603.
Across 28 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$152
- Aerin Medical Inc.$103
- ARS Pharmaceuticals Operations, Inc.$86
- GSK$53
- AstraZeneca$34
- Genentech USA, Inc.$30
- plus $101 from 5 others
What the payments were for
- Food & beverage$558100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 7 | $152 |
| Aerin Medical Inc. | 5 | $103 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $86 |
| GSK | 3 | $53 |
| AstraZeneca | 2 | $34 |
| Genentech USA, Inc. | 2 | $30 |
| Smith+Nephew | 2 | $29 |
| Sanofi | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Intersect ENT, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$558 in reported general payments places this provider in the 45th percentile of 34 otolaryngology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 21 | $2,886 |
| Dexlansoprazole DrDexlansoprazole | 13 | $2,417 |
| Famotidine | 194 | $2,204 |
| Pilocarpine Hcl | 31 | $2,057 |
| Ipratropium Bromide | 54 | $1,642 |
| Azelastine Hcl | 48 | $1,542 |
| Fluocinolone Acetonide Oil | 32 | $1,478 |
| Omeprazole | 68 | $847 |
| Pantoprazole Sodium | 56 | $701 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $692 |
| Cyclobenzaprine Hcl | 43 | $687 |
| Montelukast Sodium | 57 | $667 |
| Nortriptyline Hcl | 38 | $643 |
| Dexamethasone Sodium Phosphate | 15 | $629 |
| Fluticasone Propionate | 42 | $470 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Great Falls
- Brian ThomasGreat Falls$1K
- Jeffrey BakerGreat Falls$13
- Duncan WatleyMissoula$10K
- David CaiBillings$4K
- Jonathan FowlkesMissoula$3K
- Kyle TubbsKalispell$3K
- Brian PelczarBillings$3K
- Ryan StephensonBozeman$2K
- Amanda KullBozeman$2K
- Brennan DodsonBozeman$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.